AnPac Bio-Medical Science is a biotechnology business based in the US. AnPac Bio-Medical Science shares (ANPC) are listed on the NASDAQ and all prices are listed in US Dollars.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $3.80 |
|---|---|
| 52-week range | $0.00 - $0.00 |
| 50-day moving average | $5.05 |
| 200-day moving average | $5.35 |
| Wall St. target price | $8.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-11.45 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $3.8 from 2023-07-21
| 1 week (2024-07-13) | N/A |
|---|---|
| 1 month (2024-06-20) | N/A |
| 3 months (2024-04-20) | N/A |
| 6 months (2024-01-20) | N/A |
| 1 year (2023-07-21) | 3.8 |
|---|---|
| 2 years (2022-07-22) | 1,205.84% |
| 3 years (2021-07-23) | 3.83 |
| 5 years (2019-07-20) | N/A |
| Revenue TTM | $10.7 million |
|---|---|
| Gross profit TTM | $12.3 million |
| Return on assets TTM | -52.64% |
| Return on equity TTM | -243.12% |
| Profit margin | 0% |
| Book value | $10.63 |
| Market Capitalization | $27 million |
TTM: trailing 12 months
We're not expecting AnPac Bio-Medical Science to pay a dividend over the next 12 months.
You may also wish to consider:
AnPac Bio-Medical Science's shares were split on a 1:20 basis on 3 November 2022. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your AnPac Bio-Medical Science shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for AnPac Bio-Medical Science shares which in turn could have impacted AnPac Bio-Medical Science's share price.
Over the last 12 months, AnPac Bio-Medical Science's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AnPac Bio-Medical Science's is 1.5599. This would suggest that AnPac Bio-Medical Science's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put AnPac Bio-Medical Science's beta into context you can compare it against those of similar companies.
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. The company was formerly known as AnPac Bio-Medical Science Co. , Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is headquartered in Shanghai, the People's Republic of China.
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Learn the basics of put options: what they are, how they work and a few examples.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.
Check out the best-performing ETFs so far in 2024.